Zobrazeno 1 - 9
of 9
pro vyhledávání: '"de Bono, JS"'
Autor:
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Fizazi K; Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France., de Bono JS; The Institute of Cancer Research and The Royal Marsden Hospital, London, UK., Barthélémy P; Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Dorff T; Medical Oncology & Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Stirling A; ICON Cancer Centre, Queensland, Australia., Machiels JP; Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Medical Oncology, Université catholique de Louvain (UCLouvain), Belgium., Bimbatti D; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy., Kilari D; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Dumez H; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, and Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium., Buttigliero C; Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Castro E; Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Chen HC; Biostatistics, Pfizer Inc., La Jolla, CA, USA., Di Santo N; Global Product Development, Pfizer Inc., Durham, NC, USA., DeAnnuntis L; Safety, Pfizer Inc., Collegeville, PA, USA., Healy CG; Oncology, Pfizer Inc., Collegeville, PA, USA., Scagliotti GV; Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Publikováno v:
The oncologist [Oncologist] 2022 Oct 01; Vol. 27 (10), pp. e783-e795.
Autor:
Halabi S; Department of Biostatistics and Bioinformatics, School of Medicine, Duke University, Durham, NC, USA., Dutta S; Department of Mathematics and Statistics, Old Dominion University, Norfolk, VA, USA., Tangen CM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Rosenthal M; Department of Medical Oncology, Peter MacCallum Cancer Centre, Parkville, Australia., Petrylak DP; Medical Oncology, Yale School of Medicine, New Haven, CT, USA., Thompson IM Jr; President, Christus San Rosa Hospital Medical Center, San Antonio, TX, USA., Chi KN; Medical Oncology, British Columbia Cancer Agency - Vancouver Centre, Vancouver, BC, USA., De Bono JS; Division of Clinical Studies, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Araujo JC; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Logothetis C; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Eisenberger MA; Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA., Quinn DI; Genitourinary Oncology, Department of Medicine University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Fizazi K; Medical Oncology, Gustave Roussy, Villejuif, France., Morris MJ; Genitourinary Oncology Service, Department of Medicine. Memorial Sloan Kettering Cancer Center, New York, NY, USA., Higano CS; Department of Medicine, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Tannock IF; Department of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Small EJ; Department of Medicine, and University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Kelly WK; Medical Oncology and Urology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA, USA.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2020 Jan 29; Vol. 4 (2), pp. pkaa003. Date of Electronic Publication: 2020 Jan 29 (Print Publication: 2020).
Autor:
Piha-Paul SA; University of Texas MD Anderson Cancer Center, Houston, TX., Hann CL; Johns Hopkins University School of Medicine, Baltimore, MD., French CA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Cousin S; Medical Oncology, Institute Bergonié, Bordeaux, France., Braña I; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Cassier PA; Medical Oncology, Léon Bérard Cancer Center, Lyon, France., Moreno V; Medical Oncology, START Madrid-FJD, Fundación Jiménez Díaz Hospital, Madrid, Spain., de Bono JS; The Institute of Cancer Research and Royal Marsden Hospital, London, UK., Harward SD; GSK, Research Triangle Park, NC., Ferron-Brady G; GSK, Collegeville, PA., Barbash O; GSK, Collegeville, PA., Wyce A; GSK, Collegeville, PA., Wu Y; GSK, Collegeville, PA., Horner T; GSK, Collegeville, PA., Annan M; GSK, Collegeville, PA., Parr NJ; UCB Celltech, Slough, UK., Prinjha RK; Division of Medical Oncology, Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Carpenter CL; Rubius Therapeutics, Cambridge, MA., Hilton J; Division of Medical Oncology, Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Hong DS; University of Texas MD Anderson Cancer Center, Houston, TX.; Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Medical Oncology, Institute Bergonié, Bordeaux, France.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Medical Oncology, Léon Bérard Cancer Center, Lyon, France.; Medical Oncology, START Madrid-FJD, Fundación Jiménez Díaz Hospital, Madrid, Spain.; The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; GSK, Research Triangle Park, NC.; GSK, Collegeville, PA.; UCB Celltech, Slough, UK.; Division of Medical Oncology, Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.; Rubius Therapeutics, Cambridge, MA.; Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Haas NB; Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA., Markowski MC; Johns Hopkins University School of Medicine, Baltimore, MD., Dhar A; GSK, Collegeville, PA., O'Dwyer PJ; University of Texas MD Anderson Cancer Center, Houston, TX.; Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Medical Oncology, Institute Bergonié, Bordeaux, France.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Medical Oncology, Léon Bérard Cancer Center, Lyon, France.; Medical Oncology, START Madrid-FJD, Fundación Jiménez Díaz Hospital, Madrid, Spain.; The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; GSK, Research Triangle Park, NC.; GSK, Collegeville, PA.; UCB Celltech, Slough, UK.; Division of Medical Oncology, Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.; Rubius Therapeutics, Cambridge, MA.; Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2019 Nov 06; Vol. 4 (2), pp. pkz093. Date of Electronic Publication: 2019 Nov 06 (Print Publication: 2020).
Autor:
Lee CP; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom; chooi.lee@boehringer-ingelheim.com., Taylor NJ; Mount Vernon Cancer Centre, Northwood, United Kingdom;, Attard G; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom;, Pacey S; Department of Oncology, The University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom;, Nathan PD; Mount Vernon Cancer Centre, Northwood, United Kingdom;, de Bono JS; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom;, Temple G; Boehringer Ingelheim Ltd, Bracknell, United Kingdom;, Bell S; Boehringer Ingelheim Ltd, Bracknell, United Kingdom;, Stefanic M; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany;, Stopfer P; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany;, Tang A; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom;, Koh DM; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom;, Collins DJ; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom; Cancer Research UK and Engineering and Physical Sciences Research Council Cancer Imaging Centre, Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom., d'Arcy J; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom; Cancer Research UK and Engineering and Physical Sciences Research Council Cancer Imaging Centre, Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom., Padhani AR; Mount Vernon Cancer Centre, Northwood, United Kingdom;, Leach MO; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom; Cancer Research UK and Engineering and Physical Sciences Research Council Cancer Imaging Centre, Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom., Judson IR; Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom;, Rustin GJ; Mount Vernon Cancer Centre, Northwood, United Kingdom;
Publikováno v:
The oncologist [Oncologist] 2015 Apr; Vol. 20 (4), pp. 368-9. Date of Electronic Publication: 2015 Mar 20.
Autor:
Ferraldeschi R; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK., Attard G, de Bono JS
Publikováno v:
Clinical chemistry [Clin Chem] 2013 Jan; Vol. 59 (1), pp. 75-84. Date of Electronic Publication: 2012 Nov 30.
Autor:
Attard G; The Institute of Cancer Research, Sutton, Surrey SM2 5PT, UK. Gerhardt.attard@icr.ac.uk, Reid AH, Auchus RJ, Hughes BA, Cassidy AM, Thompson E, Oommen NB, Folkerd E, Dowsett M, Arlt W, de Bono JS
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2012 Feb; Vol. 97 (2), pp. 507-16. Date of Electronic Publication: 2011 Dec 14.
Autor:
Sartor O; Tulane Cancer Center, Tulane University, New Orleans, LA, USA., Michels RM, Massard C, de Bono JS
Publikováno v:
The oncologist [Oncologist] 2011; Vol. 16 (11), pp. 1487-97. Date of Electronic Publication: 2011 Nov 02.
Autor:
Papadatos-Pastos D; Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK., Dedes KJ, de Bono JS, Kaye SB
Publikováno v:
The oncologist [Oncologist] 2011; Vol. 16 (10), pp. 1413-21. Date of Electronic Publication: 2011 Sep 23.
Autor:
de Bono JS; Institute for Drug Development, Cancer Therapy and Research Center, 7979 Wurzbach Road, 4th Floor Zeller Building, San Antonio, TX 78229, USA., Rowinsky EK
Publikováno v:
British medical bulletin [Br Med Bull] 2002; Vol. 64, pp. 227-54.